NT-proBNP is an established indicator of heart failure and cardiovascular stress with dynamic response to disease state and treatment [21–23], while IL-6 is a cytokine that is upstream of C-reactive protein and provides a complementary marker of systemic inflammation, which has been successfully targeted in the treatment of CVD [24]. Here, NPPB is linked to heart failure.